We are excited to share that we have raised $43 million in series A financing to continue on our mission to decarbonise industry at scale by turning CO2 into valuable products.
Finally, none of this would have been possible without the amazing work of the entire Again team, who are pushing the boundaries of biotechnology to solve the climate crisis.
The round was co-led by @HV_Capital and @GVteam , with participation from @kompas_vc, @Eifo_fond and CSC, as well as our existing investors @ACME and Atlantic Labs.
We are excited to share that we have raised $43 million in series A financing to continue on our mission to decarbonise industry at scale by turning CO2 into valuable products.
By combining our CO2-eating bacteria with cutting-edge technology, we're on a mission to turn CO2 into valuable materials.
We are excited to lift the lid on our first production facility, which went live in late 2023 in Copenhagen.
https://t.co/v1MYPlbC5I